Dyne Therapeutics, Inc. (DYN) NASDAQ
17.24
-1.39(-7.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.51B |
| Enterprise Value | 1.64B |
| P/E Ratio | -6.33 |
| PEG Ratio | -0.66 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.3 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.42 |
| Return On Equity | -0.58 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.05M |
| EBITDA | -437.97M |
| Net Income | -446.21M |
| Diluted EPS | -3.47 |
Balance Sheet
| Total Cash | 972.16M |
| Total Cash/Share | 5.89 |
| Total Debt | 19.3M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 19.92 |
| Book Value Per Share | 5.24 |
Price History
| 52-Week Change | 36.33 |
| 52-Week High | 25 |
| 52-Week Low | 8.06 |
| Moving Average 50 Days | 18.29 |
| Moving Average 200 Days | 17.33 |
Statistics
| Average Volume | 1.95M |
| Shares Outstanding | 165.31M |
| % Held by Institutions | 146.25 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
